evidoria

← Back to browse

Good practice

Dysolve — First Independent Randomized Controlled Trial of an AI Reading-Intervention for the Lowest-Performing US Readers

United States of America · Newark · See the United States of America profile

The first independent RCT of an AI dyslexia-intervention game found a real but modest gain for the lowest-performing US readers (ITT +0.095 SD, p≈.06), rising with dosage — though most students used it far below the recommended 9 hours.

848 students
Sample size (2022-2025)
+0.095 SD
Intent-to-treat effect
+0.20 SD
Dosage-response effect per 10x usage
+0.30 SD
Projected effect at recommended 9-hour dose
Dysolve — First Independent Randomized Controlled Trial of an AI Reading-Intervention for the Lowest-Performing US Readers

Details

Maturity
Scaling
Promoter
Dysolve AI (EduNational Solutions), independently evaluated by CRESP, University of Delaware
Period
2022–2025 school years (RCT); technical report published October 2025
Keywords
AI reading intervention, dyslexia, randomized controlled trial, learning disabilities, K-12

Context

Dysolve is a game-based AI program from EduNational Solutions that autonomously generates individually tailored reading games for struggling readers, without requiring teacher training. CRESP at the University of Delaware ran the first large-scale, fully independent RCT of the program.

Results

848 students in grades 3-8 across 32 schools in 9 US states, overwhelmingly low-income and minority and scoring near the 10th percentile at baseline, were randomly assigned within grade and school over the 2022-23 through 2024-25 school years. Intent-to-treat analysis found +0.095 SD (p≈.057); a dosage analysis found +0.20 SD per 10-fold increase in usage, projecting to roughly +0.30 SD at the recommended 9-hour dose.

Conclusions

Most treatment students used Dysolve well under the recommended dose, meaning the trial likely understates the programme's potential effect under full, faithful implementation, while also showing how fragile real-world impact is when dosage isn't met.

Implementation

Implementation detail (cost, timeline, staffing, conditions for success) is not yet available for this practice.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful